Eli Lilly and Company has launched Lilly TuneLab, an artificial intelligence and machine learning...
Category - Pharmaceuticals
Koselugo Recommended for EU Approval in Adults with NF1...
AstraZeneca’s Koselugo (selumetinib) has secured a positive recommendation from the European...
SAR446268 Earns US Fast Track Designation for Non-Congenital...
Sanofi is pleased to announce that the US Food and Drug Administration (FDA) has granted Fast Track...
Enhertu plus pertuzumab granted FDA Priority Review as potential...
AstraZeneca and Daiichi Sankyo have announced that the US Food and Drug Administration (FDA) has...
Johnson & Johnson Reports Positive Phase 3 Results for...
Johnson & Johnson has released new Phase 3 clinical trial data showing that icotrokinra, a...
Sanofi’s Brivekimig Shows Positive Phase 2a Results in...
Sanofi has reported encouraging Phase 2a data for brivekimig, a dual-target Nanobody® molecule...
Pfizer and BioNTech Report Strong Immune Response from LP.8.1...
Pfizer and BioNTech have announced topline Phase 3 clinical trial data showing a robust immune...
Novartis to Acquire Tourmaline Bio, Expanding Cardiovascular...
Novartis has announced plans to acquire Tourmaline Bio, strengthening its cardiovascular pipeline...
Sanofi Gene Therapy Gains FDA Fast Track Designation for Wet Age...
Sanofi has announced that the US Food and Drug Administration (FDA) has granted Fast Track...
Libtayo Plus Chemotherapy Delivers Five-Year Survival Benefit in...
Regeneron Pharmaceuticals, Inc. has announced five-year follow-up results from its Phase 3 EMPOWER...